COVID-19 in asthma and chronic obstructive pulmonary disease
Since December 2019, the coronavirus disease 2019 (COVID-19) Caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), outbroke in Wuhan, China, and rapidly spread to all over the World.1-3 COVID-19 is an acute respiratory disease that can lead to respiratory failure and death. About 2...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Series: | Egyptian Journal of Chest Disease and Tuberculosis |
| Subjects: | |
| Online Access: | http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2021;volume=70;issue=5;spage=19;epage=22;aulast=Mohamed |
| Summary: | Since December 2019, the coronavirus disease 2019 (COVID-19) Caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), outbroke in Wuhan, China, and rapidly spread to all over the World.1-3 COVID-19 is an acute respiratory disease that can lead to respiratory failure and death. About 20%-51% of COVID-19 patients reported as having at least one comorbidity. The most prevalent comorbidity was hypertension (10%–30%), followed by diabetes (10%–20%) and coronary heart disease (7%–15%), which associated with poorer clinical outcomesIt is anticipated that chronic respiratory diseases including chronic obstructive pulmonary disease (COPD) and asthma may predispose patients to SARS-CoV-2 infection. However, the reported incidences of both diseases in patients with COVID-19 were frequently lower than the prevalence of these conditions in general population. |
|---|---|
| ISSN: | 0422-7638 2090-9950 |